Professional Documents
Culture Documents
• How to make sure you have a clear traceability thread within your TD
to demonstrate compliance to all GSPRs
Look out for the logo below and follow the link in the chat box
Intended Use
Risk Profile
No NB
Clinical evaluation consultation*
involved
MDR
Article 10.4
General obligations of manufacturers
“Manufacturers […] shall draw up and keep up to date technical
documentation […] to allow the conformity assessment of the device
with the requirements of this Regulation”
Remember: NO GRAND-FATHERING
Rationale 1
Rationale 2
Rationale 3
ISO 9001 & ISO 13485 12
Medidee Services © 2022
Certified company
2. Q&A
• The Legal Manufacturer claims conformity to ISO xyz:2016 while the tests
reports demonstrate conformity with ISO xyz:2007.
• Test report referenced in section xyz of the GSPR does not relate to the
device submitted (copy / paste mistake)
Provide Medidee
Tech-Doc
Servicesstructure
© 2022 according Annex II and III if EU
ISO 9001 & ISO 13485 15
Certified company
only (check first with NB if you want to use IMDRF ToC)
All MD SaMD Implant D.D.
1st :
Start outsourced work to
avoid bottlenecks
GAP ANALYSIS (for example lab tests,
CER…)
List of documents / tests /
validations (…) that need to
be updated or created
2nd :
Update time consuming
key documents (step 5)
(for example RM file)
ISO 9001 & ISO 13485 17
Medidee Services © 2022
Certified company
All MD SaMD Implant D.D.
Risk Analysis
User Level – aFMEA / uFMEA
Application
Analysis Evaluation Control
or Use
Analysis
Component / Function Level – dFMEA
Design Analysis Evaluation Control
Analysis
Process Level – pFMEA
PMCF PMCF
plan report
BENEFIT-RISK?
CEP CER SSCP NoBo
PSUR / NoBo
PMS PMS
plan report
ISO 9001 & ISO 13485 21
Medidee Services © 2022
Certified company
All MD SaMD Implant D.D.
• The users
Software as a
Medical Device
(SaMD)
à No cybersecurity data
à No usability data
Implantable
Medical Devices
Manufacturer:
Option to consult expert panels prior to clinical evaluation and / or
investigation Art 61 (2)
For :
• Class III implantable devices
• Class IIb active devices intended to administer and / or remove a
medicinal product
Medidee Services © 2022
ISO 9001 & ISO 13485 28
Certified company
All MD SaMD Implant D.D.
Combination Products
(Drug Delivery Products)
EMA (European Medicines Agency) will then check the file to ensure
everything is covered
àPharmaceutical companies might have to deal with NB for the 1st time
• Put yourself in the position of the reviewers and take into account
the review process at your NB!
• Indicate clearly where to find the evidence (not “Risk Management
Report” but “RM Report, section 3”)
• Ensure traceability between Specs, Risk Analysis, CER, GSPR à the
V&V matrix is key
• If you deliver TD as pdf, use hyperlinks, prepare native searchable
pdf, use consistent wording
• Make meaningful summaries for each section (STED) – with links to
the further evidence
à Being updated
Digital Health
www.medidee.com